NO20081169L - Nye camptothecinanalogforbindelser, en fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem - Google Patents
Nye camptothecinanalogforbindelser, en fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende demInfo
- Publication number
- NO20081169L NO20081169L NO20081169A NO20081169A NO20081169L NO 20081169 L NO20081169 L NO 20081169L NO 20081169 A NO20081169 A NO 20081169A NO 20081169 A NO20081169 A NO 20081169A NO 20081169 L NO20081169 L NO 20081169L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- analog compounds
- camptothecin analog
- Prior art date
Links
- -1 Camptothecin Analog Compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0508364A FR2889527A1 (fr) | 2005-08-05 | 2005-08-05 | Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
PCT/FR2006/001901 WO2007017585A2 (fr) | 2005-08-05 | 2006-08-04 | Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20081169L true NO20081169L (no) | 2008-03-05 |
Family
ID=36216903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20081169A NO20081169L (no) | 2005-08-05 | 2008-03-05 | Nye camptothecinanalogforbindelser, en fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem |
Country Status (19)
Country | Link |
---|---|
US (1) | US20100168149A1 (zh) |
EP (1) | EP1910377A2 (zh) |
JP (1) | JP2009503039A (zh) |
KR (1) | KR20080032007A (zh) |
CN (1) | CN101238133A (zh) |
AR (1) | AR056189A1 (zh) |
AU (1) | AU2006277863A1 (zh) |
BR (1) | BRPI0614608A2 (zh) |
CA (1) | CA2617957C (zh) |
EA (1) | EA014689B1 (zh) |
FR (1) | FR2889527A1 (zh) |
GE (1) | GEP20115243B (zh) |
MA (1) | MA29653B1 (zh) |
MX (1) | MX2008001560A (zh) |
MY (1) | MY150497A (zh) |
NO (1) | NO20081169L (zh) |
UA (1) | UA95253C2 (zh) |
WO (1) | WO2007017585A2 (zh) |
ZA (1) | ZA200801991B (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2889528B1 (fr) * | 2005-08-05 | 2007-09-07 | Servier Lab | Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
WO2014127214A1 (en) | 2013-02-15 | 2014-08-21 | Kala Pharmaceuticals, Inc. | Therapeutic compounds and uses thereof |
JP2016510000A (ja) | 2013-02-20 | 2016-04-04 | カラ ファーマシューティカルズ インコーポレイテッド | 治療用化合物およびその使用 |
US9688688B2 (en) | 2013-02-20 | 2017-06-27 | Kala Pharmaceuticals, Inc. | Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof |
US9890173B2 (en) | 2013-11-01 | 2018-02-13 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
CA2928658A1 (en) | 2013-11-01 | 2015-05-07 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
CN106188079A (zh) * | 2016-07-09 | 2016-12-07 | 兰州大学 | 喜树碱7‑位哌嗪硫脲类化合物、制备方法和用途 |
US10392399B2 (en) | 2016-09-08 | 2019-08-27 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
US10253036B2 (en) | 2016-09-08 | 2019-04-09 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
AU2017324251A1 (en) | 2016-09-08 | 2019-03-21 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
CN110357897A (zh) * | 2019-07-26 | 2019-10-22 | 上海健康医学院 | 一种具有抗肿瘤活性的喜树碱衍生物及其制备方法和应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6111107A (en) * | 1997-11-20 | 2000-08-29 | Enzon, Inc. | High yield method for stereoselective acylation of tertiary alcohols |
FR2801309B1 (fr) * | 1999-11-18 | 2002-01-04 | Adir | Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US6699876B2 (en) * | 1999-11-18 | 2004-03-02 | Les Laboratoires Servier | Camptothecin analogue compounds |
US6403604B1 (en) * | 2001-03-01 | 2002-06-11 | California Pacific Medical Center | Nitrogen-based camptothecin derivatives |
WO2003101998A1 (en) * | 2002-06-03 | 2003-12-11 | California Pacific Medical Center | Nitrogen-based homo-camptothecin derivatives |
CN100443486C (zh) * | 2002-09-11 | 2008-12-17 | 中国医学科学院药物研究所 | 7-酯化和7,20-双酯化的喜树碱衍生物及其制法和其药物组合物与用途 |
FR2889528B1 (fr) * | 2005-08-05 | 2007-09-07 | Servier Lab | Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2005
- 2005-08-05 FR FR0508364A patent/FR2889527A1/fr active Pending
-
2006
- 2006-04-08 UA UAA200802668A patent/UA95253C2/ru unknown
- 2006-08-03 MY MYPI20063757 patent/MY150497A/en unknown
- 2006-08-04 MX MX2008001560A patent/MX2008001560A/es active IP Right Grant
- 2006-08-04 BR BRPI0614608A patent/BRPI0614608A2/pt not_active IP Right Cessation
- 2006-08-04 ZA ZA200801991A patent/ZA200801991B/xx unknown
- 2006-08-04 CA CA2617957A patent/CA2617957C/fr not_active Expired - Fee Related
- 2006-08-04 AU AU2006277863A patent/AU2006277863A1/en not_active Abandoned
- 2006-08-04 AR ARP060103405A patent/AR056189A1/es unknown
- 2006-08-04 EP EP06794288A patent/EP1910377A2/fr not_active Withdrawn
- 2006-08-04 US US11/990,065 patent/US20100168149A1/en not_active Abandoned
- 2006-08-04 WO PCT/FR2006/001901 patent/WO2007017585A2/fr active Application Filing
- 2006-08-04 KR KR1020087005342A patent/KR20080032007A/ko not_active Application Discontinuation
- 2006-08-04 EA EA200800393A patent/EA014689B1/ru not_active IP Right Cessation
- 2006-08-04 CN CNA2006800286572A patent/CN101238133A/zh active Pending
- 2006-08-04 GE GEAP200610531A patent/GEP20115243B/en unknown
- 2006-08-04 JP JP2008524549A patent/JP2009503039A/ja active Pending
-
2008
- 2008-01-28 MA MA30610A patent/MA29653B1/fr unknown
- 2008-03-05 NO NO20081169A patent/NO20081169L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MA29653B1 (fr) | 2008-07-01 |
WO2007017585A2 (fr) | 2007-02-15 |
CN101238133A (zh) | 2008-08-06 |
FR2889527A1 (fr) | 2007-02-09 |
EA014689B1 (ru) | 2010-12-30 |
GEP20115243B (en) | 2011-06-27 |
CA2617957A1 (fr) | 2007-02-15 |
MY150497A (en) | 2014-01-30 |
US20100168149A1 (en) | 2010-07-01 |
MX2008001560A (es) | 2008-02-15 |
EP1910377A2 (fr) | 2008-04-16 |
AU2006277863A1 (en) | 2007-02-15 |
WO2007017585A3 (fr) | 2007-04-12 |
CA2617957C (fr) | 2011-09-20 |
EA200800393A1 (ru) | 2008-08-29 |
UA95253C2 (ru) | 2011-07-25 |
BRPI0614608A2 (pt) | 2016-11-16 |
ZA200801991B (en) | 2009-08-26 |
KR20080032007A (ko) | 2008-04-11 |
AR056189A1 (es) | 2007-09-26 |
JP2009503039A (ja) | 2009-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20081169L (no) | Nye camptothecinanalogforbindelser, en fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
NO20055688L (no) | Organiske forbindelser | |
NO20081217L (no) | Nye benzotiazolonderivater | |
NO20092689L (no) | Quinuclidinolderivater som muskarin reseptorantagonister | |
NO20071504L (no) | Pyrimidinderivanter. | |
NO20070339L (no) | 1-aza-bicyklo[3 3.1]nonaner | |
NO20050635L (no) | Nye tricykliske spiropiperidiner eller spiropyrrolidiner | |
EP1982982A4 (en) | NEW COUMARINE DERIVATIVE WITH ANTITUM EFFECT | |
TW200732323A (en) | Organic compounds | |
NO20085176L (no) | Fenyl substituerte heteroaryl-derivater og andvendelse som anti-tumor agenter | |
NO20081729L (no) | Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer | |
NO20074093L (no) | Fremgangsmater for fremstilling av glukopyranosyl-substituerte benzyl-benzenderivater og mellomprodukter derav | |
NO20083434L (no) | Benzamid- og heteroarenderivater | |
NO20073663L (no) | Tiazol-4-karboksamid-derivater som mGluR5 antagonister | |
NO20083909L (no) | Bisykliske benzimidazolforbindelser, og deres anvendelse som metabotropiske glutamatreseptorforsterkere | |
NO20071593L (no) | Pyrimidinderivater | |
ES2368594T3 (es) | Derivados sustituidos de ciclohexilmetilo. | |
NO20081001L (no) | Derivater av karboksamid som antagonister for muskarinisk reseptor | |
JO2770B1 (en) | Organic compounds | |
NO20064160L (no) | Nye azaibicykliske forbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
NO20073572L (no) | Nye forbindelser | |
MY154962A (en) | Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a seratonin receptor | |
NO20062900L (no) | Nye forbindelser | |
NO20080394L (no) | N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav | |
NO20062533L (no) | 5-fluor, 5-klor- og cyanopyridin-2-yl-tetrazoler som ligander for den metabotrofe glutamatreseptor-5 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |